Enesi and BARDA to co-develop flu vaccines
admin 16th April 2019 Uncategorised 0The public-private partnership aims to provide a cost-effective technological innovation. More: Enesi and BARDA to co-develop flu vaccines Source: News
read more
The public-private partnership aims to provide a cost-effective technological innovation. More: Enesi and BARDA to co-develop flu vaccines Source: News
read moreOver 6,250 care homes have already signed up to the system, which is accessible on any device. More: New digital tool helps relieve pressure on NHS Source: News
read moreAjinomoto Bio-Pharma Services has concluded a deal that will allow the CDMO to operate in the gene therapy space. The company has fully integrated oligonucleotides producer GeneDesign into its operations. More: Japan's Ajinomoto Bio-Pharma Services takes control of GeneDesign Source:
read moreAllergan has fought hard—and controversially—to protect its patents for blockbuster eye medicine Restasis with the help of a Native American tribe, but that effort seems to be reaching an end. More: Supreme Court sends Allergan packing over Restasis tribal licensing
read moreAfter a tough year in the competitive multiple sclerosis field, Sanofi’s Lemtrada could hardly afford another setback. But that’s exactly what it received last week. The EMA has recommended temporary restriction of Lemtrada’s use as the agency reviews reports of
read moreAllergan has been warring with upset investors who are pushing for a change to the company’s leadership structure, but leading proxy adviser firms aren’t on board. More: Proxy advisers back Allergan in leadership fight, but investors may not be happy:
read more© 1994 - 2026 B.M. Pharmaceuticals